Introduction
Gastric cardia adenocarcinoma (GCA) represents the second leading cause of cancer-related death worldwide, with .700 000 deaths each year (1) . In the last two decades, although incidence rate of non-cardia gastric cancer has slightly declined, GCA has shown a significantly increased trend in China (2) . Since most patients in early stage of GCA have no obvious symptoms, the early diagnosis of GCA is challenging. Therefore, despite the advances in treatment strategies, GCA still has a dismal prognosis, with much lower 5 years survival compared with cancer at the pyloric antrum (3). The rapid increase in incidence and poor prognosis of GCA highlight the importance of prevention against the disease. Epidemiological studies have suggested several environmental factors that are involved in the development of GCA, including cigarette smoking, alcohol consumption, pathogenic infections and dietary carcinogen exposure (4, 5) . However, only a fraction of exposed individuals actually developed GCA during their lifespan, suggesting that this malignancy may result from interactions of multiple environmental and genetic factors.
The development of GCA, among other cancers, has been thought to be of multisteps (5) . The initiation of carcinogenesis is probably caused by metabolic activation of carcinogens via phase I enzymes that convert carcinogens into DNA-damaging metabolites (6) . Competing with this is the metabolic detoxification of carcinogens to harmless excreted products primarily by phase II enzymes (7) . The balance between metabolic activation and detoxification of carcinogens by various enzymes varies among individuals and has been shown to modulate cancer susceptibility (5) . If cellular DNA damages can be fixed by repair system, the cell is returned to its normal state. On the other hand, the cell with permanently damaged DNA may be arrested by cell cycle control and removed by apoptosis or programmed cell death. However, if DNA damages escape from cellular repair mechanisms and persist, permanent mutation and malignant transformation may occur to the cell, resulting in cancer under the circumstance of the loss of normal growth control (8) . Additionally, many studies have shown that aberrant extracellular proteolysis might also be implicated in cancer development. For example, elevated expression of matrix metalloproteinases (MMPs) has been recognized as a critical modulator for cancer initiation and development by regulating various signaling pathways involved in cell growth, differentiation, apoptosis, angiogenesis and immune surveillance (9, 10) . Previous studies have shown that functional variations in genes involved in carcinogen metabolism (e.g. CYP2E1 and SULT1A1), DNA repair (e.g. XPC and XRCC1), cell cycle control (e.g. STK15), apoptosis (e.g. P53, FAS and FASL) and proteolysis (e.g. MMP-2) may be individually associated with susceptibility to GCA (6, (11) (12) (13) (14) (15) (16) (17) .
Although certain genetic polymorphisms have been associated with GCA susceptibility, the previous studies, which usually used single gene-or polymorphism-based design, often yield conflicting results across different studies. Furthermore, since cancers are complex diseases involving multiple genetic variations and gene-environment interactions, not a single locus can fully explain their genetic susceptibility. Some previous studies suggested the possibility of gene-gene and gene-environment interactions; however, these interactions are difficult to fully characterize using traditional analytic strategies such as logistic regression (LR) since sparseness of the data in high dimensions would occur to result in inaccuracy parameter estimates for identifying interactions. Additionally, statistic power would decrease and type II errors would increase when detecting interactions by LR in relatively small sample size (18, 19) . Recently, two non-parametric data mining approaches, multifactor dimensionality reduction (MDR) and classification and regression tree (CART) have been documented to overcome the inaccuracy parameter estimates and low power of LR for detecting interactions and have good power for identifying high-order interactions (18, 20) . Given the statistical advantages in identifying complex interactions, MDR and CART have been applied to explore high-order gene-gene and gene-environment interactions in modulating risk of various types of cancer (21) (22) (23) .
In this study, we investigated a panel of 12 well-studied polymorphisms in nine genes involved in carcinogen metabolism, DNA repair, cell cycle control, apoptosis and proteolysis (6, (11) (12) (13) (14) (15) (16) (17) in a casecontrol study of 344 GCA patients and 324 cancer-free controls. We examined the individual and combined effects of these 12 polymorphisms by traditional unconditional LR model and high-order gene-gene and gene-smoking interactions in modulating GCA risk using MDR and CART analyses.
Patients and methods

Study subjects
This study consisted of 344 patients with newly diagnosed GCA and 324 cancer-free controls. All subjects were unrelated ethnic Han Chinese. Patients were consecutively recruited between January 1997 and July 2003 at the Cancer hospital, Chinese Academy of Medical Sciences (Beijing). GCA was defined as tumor arising at the gastric cardia and/or gastroesophageal junction with or without involvement of other esophageal and/or gastric subsites. Tumors confined entirely to the esophageal or gastric subsites were excluded. All patients with histopathologically confirmed GCA were enrolled, yielding a response rate of 94%. Controls were cancer-free individuals living in Beijing region, who were randomly selected from an endoscopic screening campaign in the same time period as the patients were enrolled, with a response rate of 96%. Controls were frequency matched to patients for age (±5 years) and sex. At recruitment, informed consent was obtained from each subject and the information on demographic characteristics, such as sex, age and smoking habit, was collected by questionnaire. Subjects who had never smoked or smoked ,1 cigarette per day and ,1 year in their lifetime were defined as non-smokers; otherwise, they were considered as smokers (including current smokers and ex smokers). For smokers, the number of pack-years smoked was calculated to indicate the cumulative smoking dose [pack-years 5 (cigarettes per day/20) Â (years smoked)]. Light and heavy smokers were categorized by using the median pack-year value of the controls as the cut points. This study was conducted under the approval of the institutional review board of the Chinese Academy of Medical Science Cancer Institute.
Genotype determination
On the basis of previous functional and epidemiological studies and common frequency in the Chinese population (6, (11) (12) (13) (14) (15) (16) (17) , we selected a total of 12 literature-defined functional polymorphisms in nine important genes involved in different processes of carcinogenesis. These included two singlenucleotide polymorphisms (SNPs) in carcinogen metabolism genes (CYP2E1 G-1293C rs3813867 and SULT1A1 Arg213His rs9282861), five SNPs in the DNA repair genes (XRCC1 T-77C rs3213245, Arg194Trp rs1799782, Arg280His rs25489, Arg399Gln rs25487 and XPC PATþ/-), one SNP in cell cycle control gene (STK15 Phe31Ile rs2273535), three SNPs in apoptotic genes (P53 Arg72Pro rs1042522, FAS G-1377A rs2234767 and FASL T-844C rs763110) and one SNP in extracellular proteolytic gene (MMP-2 C-1306T rs243865) (supplementary Table 1 is available at Carcinogenesis Online). Genomic DNA was extracted from 5 ml blood sample that was collected from each participant at recruitment. Genotypes of all polymorphisms were determined by polymerase chain reaction-restriction fragment length polymorphism assays except for the XPC poly AT insertion/deletion polymorphism (PATþ/-) and MMP-2 C-1306T polymorphism, which were analyzed by polymerase chain reaction-amplified fragment length polymorphism and polymerase chain reaction-denatured high performance liquid chromatography, respectively (24, 25) . Genotyping was performed without knowledge of case/control status of the subjects. A 10% masked, random sample of cases and controls were tested twice by different people and the reproducibility was 100%.
Statistical analysis
Difference in the distribution of demographic characteristics and genotype frequencies between cases and controls were evaluated using the v 2 -test, Fisher's exact test and t-test, where appropriate. Hardy-Weinberg equilibrium for genotypes was tested in controls by a goodness-of-fit v 2 -test. Unconditional multivariate LR was used to estimate odds ratios (ORs) and their 95% confidence intervals (CIs) adjusting for age, sex, smoking status or pack-years, where appropriate. The potential gene-environment interaction between polymorphism and cigarette smoking was evaluated by genotype-smoking combined effect and multiplicative interaction term that considered cumulative smoking dose as discrete variables: non-smokers, light smokers ( 27 packyears) and heavy smokers (.27 pack-years). For multiple testing, a powerful bootstrapping method was applied to reduce the potential spurious findings. All statistical analyses were conducted using SPSS software (version 18.0).
MDR analysis
The MDR software (version 2.0 beta 8) and MDR permutation testing software (version 1.0 beta 2) were applied to identify possible high-order interactions associated with GCA risk. The MDR is a non-parametric, genetic model-free method for overcoming some of the limitations of LR (i.e. sample size limitations) for the detection and characterization of gene-gene and gene-environment interactions (18) . MDR collapses high-dimensional data into a single dimensional variable with two levels (high and low risk) using the ratio of the number of patients to the number of controls, thereby reducing the high-dimensional data to a single variable and permitting detection of interactions in relatively small sample sizes. The one-dimensional multifactor variable was evaluated for its ability to classify and predict disease status through cross-validation and permutation testing scheme. MDR was utilized to generate a single model that maximized the number of individuals with the proper risk assignment. In this study, the best candidate interaction model was selected across all multilocus models that maximized testing accuracy and the cross-validation consistency (CVC). Furthermore, validation of models as effective predictors of disease status was derived empirically from 1000 permutations, which accounted for multiple comparison testing as long as the entire model fitting procedure was repeated for each randomized dataset to provide an opportunity to identify false positives. The MDR permutation results were considered to be statistically significant at the 0.05 level. All the variables identified in the best model were combined and dichotomized according to the MDR software and their ORs and 95% CIs in relation to GCA risk were calculated. Finally, combined effect of the variables in the best model by the number of risk genotypes was evaluated using LR analysis.
CART analysis CART analysis was performed using the SPSS software to build a decision tree via recursive partitioning. A CART is constructed by splitting a node into two child nodes repeatedly, beginning with the root node that contains the whole learning sample. Before growing a tree, we choose measure for goodness of split using Gini criteria, by which splits were found that maximize the homogeneity of child nodes with respect to the value of the target variable. After the tree is grown to its full depth, a pruning procedure was performed to avoid overfitting the model. Subgroups of individuals with differential risk associations with GCA were identified in the different terminal nodes of the tree, indicating potential presence of interactions. Finally, the risk of these subgroups was evaluated by using the LR analysis. ORs and 95% CIs were adjusted for age and sex, with treating the least percentage of cases as the reference.
Results
Characteristics of study subjects Age and sex were frequency matched among 344 GCA cases and 324 cancer-free controls. Distributions of smokers and non-smokers in cases and controls were similar and light or heavy smokers who had smoked 27 or .27 pack-years were also not significantly different among cases and controls (Table I) . (Table II) .
We further assessed the combined effect or interaction between aforementioned six polymorphisms and trichotomized cumulative smoking dose. As shown in Table III , there was a significant twoway multiplicative interaction between SULT1A1 Arg213His and smoking (P 5 0.020), and the interaction was still significant when adjusting for multiple comparisons by bootstrapping (P 5 0.026). Analysis of combined effect revealed that heavy smokers carrying at least one SULT1A1 213His allele had significantly increased GCA risk (OR 5 2.19, 95% CI, 1.27-3.76) compared with nonsmokers without the SULT1A1 213His allele.
Association of high-order interactions with GCA risk by MDR analysis Table IV shows the best interaction model by MDR analysis. The best one-factor model for predicting GCA risk was MMP-2 C-1306T SNP (testing accuracy 5 0.595, CVC 5 10/10, permutation P , 0.005). The best two-factor model of MMP-2 C-1306T and FASL T-844C had an improved testing accuracy of 0.616 (CVC 5 10/10, permutation P , 0.005). The best interaction model was the three-factor model including MMP-2 C-1306T, FASL T-844C and FAS G-1377A SNPs, which yielded the highest testing accuracy of 0.632 and the maximal CVC of 10/10 (permutation P , 0.001). The four-factor model consisting of MMP-2 C-1306T, FASL T-844C, FAS G-1377A and SUL-T1A1 Arg213His and five-factor model consisting of MMP-2 C-1306T, FASL T-844C, FAS G-1377A, SULT1A1 Arg213His and XRCC1 Arg399Gln also improved testing accuracy compared with the one-factor model (permutation P 5 0.006 and P , 0.013, respectively); however, the CVCs were decreased (9/10 and 6/10, respectively).
For the three SNPs identified in the best interaction model, MMP-2 C-1306T, FASL T-844C and FAS G-1377A were combined and dichotomized according to the MDR software. Individuals carrying the combined risk stratum had a 2.99-fold increased risk for GCA (95% CI, 2.18-4.11; P , 0.001). Furthermore, a combined effect of MMP-2 C-1306T, FASL T-844C and FAS G-1377A was evaluated by LR analysis (Table V) with the MMP-2 -1306CC, FASL -844CC and FAS -1377AA genotypes as risk genotypes. Subjects were categorized into four groups based on the number of risk genotypes they carried and those without any risk genotype were designated as the reference group. We found that the OR of GCA for individuals carrying one, two or three risk genotypes was 2.07 (95% CI, 1.18-3.65), 4.85 (95% CI, 2.74-8.60) or 6.60 (95% CI, 2.76-15.76), suggesting a significant gene dose effect (P trend 5 4.736 Â 10 À12 ).
Analysis of gene-environment interaction was also performed using the 12 SNPs and the trichotomized cumulative smoking dose by MDR analysis. However, no significant interaction between smoking and any SNP was found.
Association of high-order interactions with GCA risk by CART analysis
The final resulting tree generated by the CART analysis is shown in supplementary Figure 1 (available at Carcinogenesis Online) and Table VI . Consistent with the MDR best one-factor model, the initial The best model was selected as the onewith the maximum testing accuracy and maximum CVC. In this study, the best interaction model was the three-factor model including MMP-2 C-1306T, FASL T-844C and FAS G-1377A polymorphisms. Data calculated by LR, adjusted for sex, age and smoking status.
b P values for gene-smoking interaction were calculated using the multiplicative interaction term in SPSS software.
Multiple interaction analysis of genetic variations and GCA split of the root node on the decision tree was MMP-2 C-1306T SNP, suggesting that this SNP is the strongest risk factor for GCA among the polymorphisms examined. Further inspection of the tree structure revealed distinct interaction patterns between individuals carrying the MMP-2 -1306CT or TT and those with the MMP-2 -1306CC genotype. Individuals carrying at least one MMP-2 -1306T allele (-1306CT or TT genotype) had the lowest risk for GCA with a rate of 31.2% cases. Using the terminal node comprising the MMP-2 -1306CT or TT genotype carriers as the reference, individuals carrying both the MMP-2 -1306CC and FASL -844CC genotypes exhibited a significantly higher risk for GCA (adjusted OR 5 4.27; 95% CI, 2.80-6.52), whereas individuals with the combined genotypes of MMP-2 -1306CC, FASL -844TT or TC and FAS -1377AA had the highest risk for GCA (adjusted OR 5 4.58; 95% CI, 2.07-10.14). Furthermore, individuals carrying combined genotypes of MMP-2 -1306CC, FASL -844TT or TC, FAS -1377GG or GA and SULT1A1 213Arg/His or His/His also had significantly increased risk (OR 5 3.03, 95% CI, 1.59-5.79).
Discussion
In this study, we applied a multi-analytic strategy combining LR, MDR and CART approaches to systematically examine the associations between GCA risk and a panel of genetic polymorphisms involved in carcinogen metabolism, DNA repair, cell cycle control, apoptosis and extracellular proteolysis. In the single-locus analysis, six polymorphisms showed significant association with GCA risk.
Results from LR, MDR and CART analyses consistently suggested that MMP-2 C-1306T polymorphism was the most important single susceptibility factor for GCA development. Furthermore, LR, MDR and CART analyses also consistently revealed the prediction value of gene-gene interaction among MMP-2 C-1306T, FASL T-844C and FAS G-1377A polymorphisms in GCA risk. To the best of our knowledge, this is the first study showing that complex gene-gene interactions may significantly contribute to GCA susceptibility. Although MMP-2 was traditionally considered to be important in late steps of cancer progression (invasion and metastasis) due to its proteolysis of extracellular matrix, current understanding of the effects of MMP-2 is particularly relevant to both cancer initiation and progression because this enzyme cleaves a diverse non-extracellular matrix substrates to modulate cell proliferation, apoptosis, angiogenesis and immune surveillance (10) . For instance, it has been shown that MMP-2 is capable of cleaving insulin-like growth factor binding proteins and releasing insulin-like factors, which is a stimulator of malignant cell proliferation (9) . MMP-2 can convert protumor necrosis factor-a to its soluble cytokinetic form, promoting cancer survival (26) . MMP-2 may also increase the bioavailability of vascular endothelial growth factor to trigger angiogenesis (27) . Additionally, MMP-2 can cleave cell adhesion molecule E-cadherin and liberate transforming growth factor-b to promote epithelialmesenchymal transition, which is associated with malignant cell invasion (28) . Moreover, MMP-2 has been shown to be overexpressed in a wide variety of human cancers, strongly supporting its importance in cancer development (29, 30) . In our LR single-locus analysis, the MMP-2 C-1306T SNP showed the strongest association with GCA risk and consistent results were also obtained by both MDR and CART analysis, indicating the MMP-2 C-1306T variant as the predominant risk factor for GCA. The consistent results across three different analytic approaches demonstrate a true association between this polymorphism and susceptibility to GCA development. The -1306C/T change is located within the MMP-2 promoter region and abolishes a transcriptional factor Sp1-binding site. Previous study has shown that reporter gene expression driven by the T allelic MMP-2 promoter was significantly lower than that driven by the C allelic promoter counterpart both in epithelial cells and macrophages (31) . Intriguingly, it was found that Mmp-2-deficient mice developed fewer tumors than wild-type mice induced by carcinogen stimulus (32) ; conversely, the induced MMP-2 expression by oncogene-mediated cellular transformation caused increased capacity for malignant progression (33) . These data strongly supported that high expression of MMP-2 might increase cancer susceptibility. Because MMP-2 plays an important role in multiple steps of cancer development and high expression of MMP-2 has been shown to be risk factor for cancer, one might expect that individuals carrying the MMP-2 -1306CC genotype are in higher susceptibility to GCA.
By LR analysis we also found that other five polymorphisms (SUL-T1A1 Arg213His, XRCC1 Arg194Trp, XPC PATþ/-, P53 Arg72Pro and FASL T-844C) were significantly associated with GCA risk and the associations remained significant after correction by bootstrapping for multiple comparisons. These results are biologically plausible because all these polymorphisms appear to be of functional significance. It has been shown that SULT1A1 encoded by the SULT1A1 213His allele has 2-fold lower catalytic activity and thermo stability than SULT1A1 produced by the SULT1A1 213Arg allele, thereby reducing this enzyme activity in metabolic detoxification of carcinogens (34) . Due to the neoconservative amino acid change, the XRCC1 194Trp variant may have changed XRCC1 function and therefore, resulting in altered DNA repair capacity (35) . The XPC PATþ allele has been shown to be in strong linkage disequilibrium with the A allele of an SNP comprising a C to A transition in intron 11 splice acceptor, and the A allele represents lower information content than the C allele and may trigger a deletion that entails the skipping of exon 12, resulting in diminished DNA repair capacity (36) . For the P53 polymorphism, the G to C change at codon 72 causes Arg to Pro amino acid substitution resulting in altered P53 function for apoptosis (37) . The T to C change at position -844 in promoter region of FASL creates a binding site for the CAAT/enhancer-binding protein b transcription factor, leading to a significantly higher basal FASL expression that has been shown to be a common feature of malignant transformation (38) .
The most significant finding in the current study was the multiple gene-gene interactions consistently identified by three different statistical approaches. MDR analysis reported the highest prediction accuracy of combined MMP-2, FASL and FAS polymorphisms for GCA risk and consistent results were also obtained by CART analysis, showing a significant interaction of these polymorphisms in the genes. Furthermore, LR analysis indicated GAC risk associated with MMP-2, FASL and FAS polymorphisms in a gene dose dependent manner, (43) . Taken together, this functional relationship among MMP-2, FASL and FAS might explain why these genes polymorphisms have statistical interaction in enhancing GCA risk. In addition, we also found a significant interaction of SNPs in MMP-2, FASL, FAS and SULT1A1 in increasing GCA risk by MDR and CART analysis, the underlying mechanism for SULT1A1 in the interaction remains to be elucidated. Interestingly, a gene-environment interaction between SULT1A1 polymorphism and smoking was also revealed in this study. Because SULT1A1 plays an important role in the metabolism of cigarette carcinogens that may promote GCA development (44) , a synergistic effect between functional SULT1A1 variant and smoking is expected. Previous study has shown reduced ability of gastric tissues carrying the SULT1A1 213His allele to detoxify cigarette carcinogens (45) .
This study might have some limitations. Because it was a hospitalbased case-control study, selection bias cannot be fully excluded. It would therefore be important to confirm these findings in a populationbased prospective study. The sample size of our study is relatively small although we had .80% power to detect a significant pairwise interaction using LR and MDR analysis based on genotype frequencies and the prevalence of smoking in our study population (46, 47) . In addition, our study lacked information on exposures to other environmental risk factors such as alcohol use, dietary consumption, pathogenic infections and further studies are needed to investigate whether these factors also interact with genetic variants in GCA risk.
In conclusion, our study highlights the contribution of the complex gene-gene and gene-environment interactions among polymorphisms involved in different processes of carcinogenesis and smoking to GCA susceptibility. Furthermore, population-based or cohort studies are required to confirm these results and more functional analyses are warranted to elucidate the biological plausibility of the complex gene-gene interactions identified in this study.
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